International Liver Cancer Association (ILCA) Avenue de Tervueren, 300 B-1150 Brussels Belgium info@ilca-online.org+32 (0)2 789 2345 +32 (0)2 743 1550 |
Speakers, Sessions, Symposia
|
|
General Session |
|
|
State-of-the-Art Lecture |
|
|
Symposium |
|
|
Special Lecture |
|
|
Industry Symposium |
|
|
Workshop |
| TIME |
Friday, 10 September |
| 08:00 – 09:30 |
ILCA Symposium 1
Management and outcomes of HCC in Asia
Chair: Sheng-Long Ye (P.R. China)
Metastatic recurrence of hepatocellular carcinoma: from –omics to clinical prediction
Lun-Xiu Qin (P.R. China)
Management and outcome of HCC in Japan: Analysis of 51,430 HCC cases registered in nationwide survey program of Liver Cancer Study Group of Japan
Masatoshi Kudo (Japan)
Surgical Management of HCC in Asia
Ronnie Poon (P.R. China) |
| 09:30 – 10:00 |
Special Lecture 1: miRNA and HCC: biology and prognostic significance
Speaker: Xin Wang (USA)
|
| 10:00 – 10:30 |
Coffee and Networking Break |
| 10:30 – 12:00 |
General Session 1: Pathways and gene expression profiles
Chairs: Yujin Hoshida, MD (USA) and Xin Wang, MD, PhD (USA) |
| 12:00 – 13:30 |
Bayer Lunch Symposium |
| 13:30 – 15:00 |
General Session 2: Biomarkers and novel targets
Chairs: Peter Schirmacher, MD (Germany) and Jorge Marrero, MD (USA) |
| 15:00 – 16:30 |
ILCA Symposium 2
Novel targets and emerging therapies
Chair: Gregory Gores (USA)
Agents on the Horizon
Alan Venook (USA)
Novel oncogenes and tumor suppressors as therapeutic targets
Peter Galle (Germany)
Novel trial designs
Steven Alberts (USA) |
| 16:30 – 17:00 |
Session Break |
| 17:00 – 18:00 |
Sirtex Symposium |
| 18:00 – 19:00 |
Welcome Reception | |
Back to top
| TIME |
Saturday, 11 September |
| 07:30 – 08:30 |
BMS Symposium |
| 08:30 – 10:00 |
ILCA Symposium 3
Assessing response in HCC – Revisiting RECIST
Chair: JM Llovet (USA/Spain)
The concept: AASLD-JNCI guidelines
JM Llovet (USA/Spain)
Comparison of RECIST and proposed mRECIST
Riccardo Lencioni (Italy)
Response assessment with molecular therapies
Richard Finn (USA) |
| 10:00 – 10:30 |
Coffee and Networking Break |
| 10:30 – 12:00 |
ILCA Plenary General Session
Chairs: Jessica Zucman-Rossi, MD, PhD (France) and Gregory Gores, MD (USA) |
| 12:00 – 13:30 |
Luncheon workshop 1
Controversies in pathology: Mixed HCC and CC
Pierre Bedossa, (France) and Tania Roskams (Belgium)
Luncheon workshop 2
Molecular Signatures and prognosis
Yujin Hoshida (USA) and Ju-Seog Lee (USA)
Luncheon workshop 3
Surgical advancements in HCC
David Geller (USA) and Vincenzo Mazzaferro (Italy)
Luncheon workshop 4
Novel concepts in HCC staging
Jordi Bruix (Spain) and Masatoshi Kudo (Japan) Luncheon workshop 5
Interventional radiology for HCC
Jean-Francois Geschwind (USA) and Riad Salem (USA) |
| 13:30 – 14:30 |
State of the Art Lecture 1
Imaging of HCC and Early Diagnosis
Morris Sherman (Canada) |
| 14:30 – 16:30 |
Poster Viewing |
| 16:00 – 16:30 |
Coffee and Networking Break |
| 16:30 – 18:00 |
General Session 3: Curative therapies
Chairs: Kim Olthoff, MD (USA) and Ronnie Poon, MD, PhD (China) | |
Back to top
| TIME |
Sunday, 12 September |
| 07:30 – 08:30 |
Novartis Symposium |
| 08:30 – 09:00 |
ILCA General Assembly |
| 09:00 – 10:30 |
General Session 4: Locoregional therapies
Chairs: Masatoshi Kudo, MD, PhD (Japan) and Riad Salem, MD (USA) |
| 10:30 – 11:30 |
State of the Art Lecture 2
Relevant experimental models of HCC
Scott Lowe (USA) - tbc |
| 11:30 – 12:00 |
Coffee and Networking Break |
| 12:00 – 13:30 |
General Session 5: Systemic therapies
Chairs: Andrew Zhu, MD, PhD (USA) and Ann-Li Chen, MD (USA) |
| 13:30 |
Closing Ceremony and Junior Investigator Awards | |
Back to top |
Conference
Membership
ILCA – an International and Multi-disciplinary
Association for Liver Cancer Experts
Find out more about ILCA Member Benefits and how to become a member.
Association
Mission
The International Liver Cancer Association (ILCA) aspires towards advancing research in the pathogenesis, prevention, and treatment of liver cancer.
|
